Increase of solubility and transmembrane permeability of niclosamide from its mechanochemically synthesized solid dispersions
Abstract
Keywords
Full Text:
PDFReferences
Krivopustov SP, Shcherbinskaya EN, Loginova IA, Chernij EF, Pavlik EV, Gerasimenko AV. Helminthiasis in clinical pediatrics: issues of diagnosis, therapy, and prevention. Child Health. 2011;4(31):71–75.
Loukas A, Hotez PJ. Chemotherapy of helminth infections. Goodman and Gilman’s the pharmacological basis of therapeutics, 11th ed. New York: McGraw-Hill. 2006: P. 1073–1093.
Arkhipov IA, Sadov KM, Limova YV, Sadova AK, Varlamova AI, Khalikov SS, Dushkin AV, Chistyachenko YS. The efficacy of the supramolecular complexes of niclosamide obtained by mechanochemical technology and targeted delivery against cestode infection of animals. Vet Parasitol. 2017;246:25–9. doi:10.1016/j.canlet.2014.04.003
Varlamova AI, Arhipov IA, Dushkin AV, Chistyachenko YUS., Limova YV, Sadov KM, Khalikov SS. Activity of supramolecular complex of anrhelmintics against Hymenolepisnana. Theory Practice Parasitic Disease Cont. 2017;(18):87–89.
Limova YV, Sadov KM, Kanatbaev SG, Arkhipov I.A. Anthelmintic efficacy of Phenasalum based on supramolecular drug delivery systems (DDS) at monieziasis in cattle. Russ J Parasitol. 2016;36:223–227. doi:10.12737/20066
Limova YV, Sadov KM, Korogodina EV, Arkhipov IA, Khalikov SS. Anthelmintic efficiency of new Phenasal formulations based on supramolecular, nanoscale drug delivery systems for anoplocephalidosis in horses. Rus J Parasitol. 2017;40:188–191.
Li Y, Li PK, Roberts MJ, Arend RC, SamantRS,Buchsbaum DJ. Multi-targeted therapy of cancer by niclosamide: A new application for an old drug. Cancer Lett. 2014;349(1):8–14. doi:10.1016/j.canlet.2014.04.003
Chen W, MookJr RA, Premont RT, Wang J. Niclosamide: Beyond an antihelminthic drug. Cell Signal. 2018;41:89–96. doi:10.1016/j.cellsig.2017.04.001
Xu J, Shi PY, Li H, Zhou J. Broad spectrum antiviral agent niclosamide and its therapeutic potential. ACS infectious diseases. 2020;6(5):909–915. doi:10.1021/acsinfecdis.0c00052
Campbell WC,Rew RS. Chemotherapy of parasitic diseases. Berlin: Springer Science & Business Media. 2013:654. doi:10.1007/978-1-4684-1233-8
Schweizer MT, Haugk K, McKiernan JS, Gulati R, Cheng HH, Maes JL, Dumpit RF, Nelson PS, Montgomery B, McCune JS, Plymate SR. A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer. PloS one. 2018;13(6):0198389. doi:10.1371/journal.pone.0198389
PubChem. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information;PubChem Compound Summary for CID 4477, Niclosamide [Internet]. 2004 [cited 2023]. English. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Niclosamide, Accessed on 27 June 2023.
Al-Hadiya BMH. Niclosamide: comprehensive profile. Profiles of Drug Subst, Excip and Relat Methodol. 2005;32:67–96. doi:10.1016/S0099-5428(05)32002-8
Ye Y, Zhang X, Zhang T, Wang H, Wu B. Design and evaluation of injectable niclosamide nanocrystals prepared by wet media milling technique. Drug Development and Industrial Pharm. 2015;41(9):1416–1424. doi:10.3109/03639045.2014.954585
Zhirnik AS, Semochkina YP, Moskaleva EY, Krylov NI, Tubasheva IA, Kuznetsov SL, Vorontsov EA. Molecular mechanisms of antitumor activity of the polymeric form of niclosamide with respect to human colorectal cancer cells. Biochem (Moscow), SupplSer B: Biomed Chem. 2017;11:301–307. doi:10.1134/S1990750817030131
Grifasi F, Chierotti MR, Gaglioti K, Gobetto R, Maini L, Braga D, Dichiarante E, Curzi M. Using salt cocrystals to improve the solubility of niclosamide. Cryst Growth & Des. 2015;15(4):1939–1948. doi:10.1021/acs.cgd.5b00106
Xie Y, Yao Y. Octenylsuccinate hydroxypropyl phytoglycogen enhances the solubility and in-vitro antitumor efficacy of niclosamide. Int J Pharm. 2018;535(1–2):157–163. doi:10.1016/j.ijpharm.2017.11.004
Rehman MU, Khan MA, Khan WS, Shafique M, Khan M. Fabrication of Niclosamide loaded solid lipid nanoparticles: in vitro characterization and comparative in vivo evaluation. Artif Cells Nanomed Biotechnol. 2018;46(8):1926–1934. doi:10.1080/21691401.2017.1396996
Bayrakcı M,Ertul S, Yilmaz M. Phase solubility studies of poorly soluble drug molecules by using O-phosphorylated calixarenes as drug-solubilizing agents. J Chem Eng Data. 2012;57(1):233–239. doi:10.1021/je200992c
Khalikov SS, Dushkin AV. Strategies for solubility enhancement of anthelmintics. Pharm Chem J. 2020;54:504–508. doi:10.1007/s11094-020-02229-4
Dushkin AV. Potential of mechanochemical technology in organic synthesis and synthesis of new materials. Chem Sustain Develop. 2004;12(3):251–273.
Arhipov IA, Sadov KM, Limova YuV, Varlamova AI, Khalikov SS, Dushkin AV, Chistyachenko YS, authors; Scientific Research Institute Parasitology named after K.I. Skryabin, assignee. Supramolekulyarnyj kompleks s niklozamidom i sposob ego polucheniya. Russian Federation patent RU 2588368 C1. 2016 June 27.
Kashapov RR, Razuvayeva YS, Ziganshina AY, Mukhitova RK, Sapunova AS, Voloshina A.D, Syakaev VV, Latypov SK, Nizameev IR, Kadirov MK, Zakharova LY. N-methyl-d-glucamine–calix [4] resorcinarene conjugates: Self-assembly and biological properties. Molec.2019;24(10):1939. doi:10.3390/molecules24101939
Needham D. The pH Dependence of Niclosamide Solubility, Dissolution, and Morphology: Motivation for Potentially Universal Mucin-Penetrating Nasal and Throat Sprays for COVID19, Its Variants and Other Viral Infections. Pharm Res. 2022;39(1):115–141. doi:10.1007/s11095-021-03112-x
Xu W, Sun Y, Du L, Chistyachenko YS, Dushkin AV, Su W. Investigations on solid dispersions of valsartan with alkalizing agents: Preparation, characterization and physicochemical properties. J Drug Delivery Sci Technol. 2018;44:399–405. doi:10.1016/j.jddst.2018.01.012
Wei W, Evseenko VI, Khvostov MV, Borisov SA, Tolstikova TG, Polyakov NE, Dushkin AV, Xu W, Min L, Su W. Solubility, permeability, anti-inflammatory action and in vivo pharmacokinetic properties of several mechanochemically obtained pharmaceutical solid dispersions of nimesulide. Molec.2021;26(6):1513. doi:10.3390/molecules26061513
Saokham P, Muankaew C, Jansook P, Loftsson T. Solubility of cyclodextrins and drug/cyclodextrin complexes. Molec. 2018;23(5):1161. doi:10.3390/molecules23051161
Hao X, Sun X, Zhu H, XieL, Wang X, Jiang N, Fu P, Sang M. Hydroxypropyl-β-cyclodextrin-complexed resveratrol enhanced antitumor activity in a cervical cancer model: In vivo analysis. Front Pharm. 2021;12:573909. doi:10.3389/fphar.2021.573909
Lodagekar A, Borkar RM, Thatikonda S, Chavan RB, Naidu VG, Shastri NR, Srinivas R, Chella N. Formulation and evaluation of cyclodextrin complexes for improved anticancer activity of repurposed drug: Niclosamide. Carbohydr Polym. 2019;212:252–259. doi:10.1016/j.carbpol.2019.02.041
Pistone M, Racaniello GF, Arduino I, Laquintana V, Lopalco A, Cutrignelli A, Rizzi R, Franco M, Lopedota A, Denora N. Direct cyclodextrin-based powder extrusion 3D printing for one-step production of the BCS class II model drug niclosamide. Drug Deliv and Translational Res. 2022;12(8):1895–1910. doi:10.1007/s13346-022-01124-7
Chistyachenko YS, Dushkin AV, Polyakov NE, et al. Polysaccharide arabinogalactan from larch Larixsibirica as carrier for molecules of salicylic and acetylsalicylic acid: preparation, physicochemical and pharmacological study. Drug Deliv. 2015;22:400–407. doi:10.3109/10717544.2014.884655
Emsley JW, Freeney J, Sutcliffe LH. High Resolution Nuclear Magnetic Resonance Spectroscopy. Vol 1. Oxford: Pergamon Press. 1967: 663 p.
Popova MV, Tchernyshev YS, Michel D. NMR Investigation of the Short-chain Ionic Surfactant− Water Systems. Langmuir. 2004;20(3):632–636. doi:10.1021/la035465s
Kerns EH, Di L, Petusky S, Farris M, Ley R, Jupp P. Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery. J Pharm Sci. 2004;93:1440–1453. doi:10.1002/jps.20075
Kansy M, Senner F, Gubernator K. Physicochemical high throughput screening: Parallel artificial membrane permeation assay in the description of passive absorption processes. J Med Chem. 1998;41:1007–1010. doi:10.1021/jm970530e
Mccallum MM. High-Throughput Approaches for the Assessment of Factors Influencing Bioavailability of Small Molecules in Pre-Clinical Drug Development [dissertation]. Milwaukee (USA) University of Wisconsin; 2013. 259 p.
DOI: https://doi.org/10.15826/chimtech.2023.10.3.07
Copyright (c) 2023 Elizaveta S. Meteleva, Elizaveta A. Roenko, Nikolay E. Polyakov
This work is licensed under a Creative Commons Attribution 4.0 International License.
© Chimica Techno Acta, 2014–2024
ISSN 2411-1414 (Online)
This journal is licensed under a Creative Commons Attribution 4.0 International